2022 - Research.com Best Female Scientist Award
Her main research concerns Breast cancer, Genetics, Genome-wide association study, Internal medicine and Genotype. The concepts of her Breast cancer study are interwoven with issues in TOX3, Single-nucleotide polymorphism and Genetic predisposition. In her study, Genomic imprinting and Genetic architecture is inextricably linked to Menarche, which falls within the broad field of Genetics.
Her Genome-wide association study study combines topics in areas such as Bioinformatics, Quantitative trait locus, Locus, 1000 Genomes Project and Candidate gene. Her Internal medicine research is multidisciplinary, relying on both Endocrinology and Oncology. Her Genotype research incorporates themes from Immunology and Allele.
Alison M. Dunning spends much of her time researching Breast cancer, Internal medicine, Oncology, Genetics and Single-nucleotide polymorphism. Her Breast cancer study integrates concerns from other disciplines, such as Genome-wide association study, Case-control study, Genetic predisposition and Genotype. Her work in Genome-wide association study addresses issues such as Genetic association, which are connected to fields such as Genetic variation.
Internal medicine and Endocrinology are commonly linked in her work. Her research integrates issues of Ovarian cancer, Radiation therapy, Toxicity and Pathology in her study of Oncology. The study incorporates disciplines such as Cancer research, Endometrial cancer and Candidate gene in addition to Single-nucleotide polymorphism.
Breast cancer, Internal medicine, Oncology, Genome-wide association study and Cancer are her primary areas of study. Alison M. Dunning is involved in the study of Breast cancer that focuses on Estrogen receptor in particular. Her research is interdisciplinary, bridging the disciplines of Single-nucleotide polymorphism and Internal medicine.
Her study in Oncology is interdisciplinary in nature, drawing from both Body mass index, Germline mutation, Cohort study, Prospective cohort study and Radiation therapy. Genome-wide association study is a subfield of Genetics that Alison M. Dunning tackles. Her Cancer research integrates issues from Relative risk, Lung cancer and Risk factor.
Alison M. Dunning mostly deals with Breast cancer, Internal medicine, Genome-wide association study, Oncology and Odds ratio. To a larger extent, she studies Cancer with the aim of understanding Breast cancer. A significant part of her Genome-wide association study research incorporates Single-nucleotide polymorphism and Genetics studies.
Her Oncology study incorporates themes from Germline mutation, PALB2, Primary tumor, Prostate cancer and Confounding. The Odds ratio study combines topics in areas such as Mendelian Randomization Analysis, Mendelian randomization, Epidemiology and Case-control study. The concepts of her Case-control study study are interwoven with issues in SNP, Polygenic risk score and Genotype.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton;Karen A. Pooley;Alison M. Dunning;Paul D. P. Pharoah.
Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study.
Gillian C. Barnett;Gillian C. Barnett;Charlotte E. Coles;Rebecca M. Elliott;Caroline Baynes.
Lancet Oncology (2012)
Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies
Fiona M. Blows;Kristy E. Driver;Marjanka K. Schmidt;Annegien Broeks.
PLOS Medicine (2010)
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
Kyriaki Michailidou;Per Hall;Anna Gonzalez-Neira;Maya Ghoussaini.
Nature Genetics (2013)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Genome-wide association study identifies five new breast cancer susceptibility loci
Clare Turnbull;Shahana Ahmed;Jonathan Morrison;David Pernet.
Nature Genetics (2010)
Beyond GWASs: illuminating the dark road from association to function.
Stacey L. Edwards;Jonathan Beesley;Juliet D. French;Juliet D. French;Alison M. Dunning.
American Journal of Human Genetics (2013)
Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.
Gillian C. Barnett;Catherine M. L. West;Alison M. Dunning;Rebecca M. Elliott.
Nature Reviews Cancer (2009)
A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk
Dunning Am;Healey Cs;Pharoah Pd;Teare.
Cancer Epidemiology, Biomarkers & Prevention (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: